PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsFibromyalgia
MeSH D005356 - fibromyalgia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012216:Rheumatic diseases
$
Success rate
D009135:Muscular diseases
0 Companies
0 Drugs
Success rate
D005356: 
Fibromyalgia
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaPregabalin Pregabalin  2019-07-19   
MylanPregabalin Pregabalin  2019-09-20   
Pregabalin Pregabalin Mylan  2015-06-24   
Pregabalin Pregabalin Mylan Pharma  2015-06-25   
CiplaPregabalin Pregabalin  2019-07-19   
Lupin ResearchPregabalin Pregabalin  2022-05-03   
SandozPregabalin Pregabalin Sandoz  2015-06-19   
Pregabalin Pregabalin Sandoz GmbH  2015-06-19   
Dr Reddys LaboratoriesPregabalin Pregabalin  2019-07-19   
Rising PharmaceuticalsPregabalin Pregabalin  2019-07-19   
Zydus TherapeuticsPregabalin Pregabalin  2022-12-09   
Sun Pharmaceutical IndustriesPregabalin Pregabalin  2019-11-29   
Alembic PharmaceuticalsPregabalin Pregabalin  2019-07-19   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
63%
19/30
Phase 2
45%
25/55
Phase 3
38%
12/32
Approved: 1Overall Success rate: 11%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use